title: Characterization of A-93178, an iminoxy-quinoline inhibitor of leukotriene biosynthesis.
authors.affiliation: Dept. 47 K, Abbott Laboratories, Abbott Park, Illinois 60064, USA.
authors.forename: R L
authors.initials: RL
authors.lastname: Bell
authors.forename: R R
authors.initials: RR
authors.lastname: Harris
authors.forename: J B
authors.initials: JB
authors.lastname: Bouska
authors.forename: K I
authors.initials: KI
authors.lastname: Hulkower
authors.forename: J
authors.initials: J
authors.lastname: Moore
authors.forename: P
authors.initials: P
authors.lastname: Bhatia
authors.forename: P E
authors.initials: PE
authors.lastname: Malo
authors.forename: T
authors.initials: T
authors.lastname: Kalosa
authors.forename: C D
authors.initials: CD
authors.lastname: Brooks
authors.forename: G W
authors.initials: GW
authors.lastname: Carter
mesh_terms: D000818:Animals; D000001:Calcimycin / Q000494:pharmacology; D004285:Dogs; D006801:Humans; D020024:Leukotriene Antagonists; D007975:Leukotriene B4 / Q000096:biosynthesis / Q000097:blood; D015289:Leukotrienes / Q000096:biosynthesis*; D016859:Lipoxygenase Inhibitors / Q000737:chemistry / Q000493:pharmacokinetics / Q000494:pharmacology*; D008657:Metabolic Clearance Rate; D015394:Molecular Structure; D009504:Neutrophils / Q000187:drug effects / Q000378:metabolism*; D011804:Quinolines / Q000737:chemistry / Q000493:pharmacokinetics / Q000494:pharmacology*
chemical_list: C112380:A 93176; D020024:Leukotriene Antagonists; D015289:Leukotrienes; D016859:Lipoxygenase Inhibitors; D011804:Quinolines; C079315:2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid; D007975:Leukotriene B4; D000001:Calcimycin